SCOTT SELLE: Open Payments
NPI 1689968406 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 25 payments from 5 companies in 2025. Trend: 2023 $379 · 2024 $334 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $259 |
| Indivior Inc. | 2 | $60 |
| Novo Nordisk Inc | 2 | $32 |
| PFIZER INC. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: UBRELVY, VRAYLAR, QULIPTA, SUBLOCADE, Ozempic, TRUMENBA, JARDIANCE.
Industry payments across MI — which companies pay providers there.
